Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K162667
    Date Cleared
    2017-05-11

    (227 days)

    Product Code
    Regulation Number
    884.6110
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Kitazato IUI Catheter is used for the introduction of washed spermatozoa into the uterine cavity through the cervix. Kitazato IUI Stylet is used to provide rigidity and assist in maintaining the shape of the catheter shaft.

    Device Description

    The Kitazato IUI Catheter is a set of intrauterine insemination (IUI) catheters comprised of two different models that include either no stainless steel core (Type 4) or a stainless steel core (Type 5). Each type of catheter has a 10 cm or 18 cm catheter shaft length that incorporates an outer stiffener component and a syringe connector. The distal tip of the catheter shaft is rounded and includes two side holes 3 mm from the tip of the catheter for sperm delivery. The catheter shaft also includes depth marker bands at 5, 6, 7, and 8 cm from the distal tip to aid in delivery of the device to the targeted depth.

    The catheter is composed of a polyvinyl chloride shaft and an acrylonitrile butadiene styrene (ABS) connector. The Stylet Cannula (Type 6) used with the Type 4 catheter is composed of a stainless steel cannula (SUS304) and an ABS syringe connector. The Stylet Cannula's stainless steel core provides rigidity and assists in maintaining the shape of the catheter shaft when the uterine cervix is sharply curved. The Stylet Cannula is inserted into the catheter shaft through the connector end and then the IUI Catheter is inserted into the cervix. During an IUI procedure, the catheter is introduced into the uterine cavity through the cervix, and the spermatozoa are injected into the uterine cavity by a syringe (not included) that is coupled at the connector end (6% taper connection) of the catheter shaft.

    AI/ML Overview

    This document describes the Kitazato IUI Catheter. Here's an analysis of the provided information concerning acceptance criteria and supporting studies:

    1. Table of Acceptance Criteria and Reported Device Performance

    TestAcceptance CriteriaReported Device Performance
    Mechanical Tensile TestingPassed established specificationsPassed
    Dimensional TestingConforms to outer diameter and length specificationsPassed
    Appearance TestingPasses visual inspection for scratches, burrs, and foreign objectsPassed
    Endotoxin Testing (per ANSI/AAMI ST72:2002/(R)2010)≤ 20 EU/deviceConforms to specification
    Sterility Testing (per USP )No microbial growthNo microbial growth
    Biocompatibility Testing (per ISO 10993-1:2009 and 2016 FDA guidance)Cytotoxicity: Passed
    Sensitization: Passed
    Irritation: PassedPassed cytotoxicity, intracutaneous reactivity (irritation), and sensitization
    Human Sperm Survival Assay (HSSA)≥ 70% motility at 24 hours≥ 70% motility at 24 hours
    Color fastness of the depth marker bandsNo change in appearance after conditioningNo change in appearance
    Shelf Life TestingEstablished three (3) year shelf lifeEstablished three (3) year shelf life
    Package Integrity Testing (per ISO 11607-1:2006(R)2014, ISO 11607-2:2006)Passed dye penetration, seal strength, and visual inspectionPassed dye penetration, seal strength, and visual inspection

    2. Sample Sizes Used for the Test Set and Data Provenance

    The document does not specify the exact sample sizes used for each individual non-clinical performance test (e.g., number of catheters tested for tensile strength, number of samples for HSSA, etc.). It only states that the device "passed all the testing."

    Data provenance is not explicitly mentioned as country of origin, however, the submission sponsor is KITAZATO Corporation in Japan, and the predicate device is from KITAZATO Medical Co., Ltd. This implies the studies were likely conducted or overseen by the Japanese manufacturer. The studies are non-clinical, implying they are laboratory-based tests rather than human studies, therefore the retrospective or prospective nature is not applicable in the same way it would be for clinical trials.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. The reported studies are non-clinical performance tests for a medical device (catheter), not diagnostic studies requiring expert interpretation of results to establish ground truth.

    4. Adjudication Method for the Test Set

    Not applicable, as these are non-clinical performance tests with objective pass/fail criteria, not subjective human-interpreted data requiring adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

    No. An MRMC comparative effectiveness study is designed for evaluating diagnostic tools where human readers are involved in interpreting results. This document describes non-clinical performance tests of a physical medical device.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    Yes, standalone performance was done in the sense that the device itself was subjected to a series of tests to verify its physical, chemical, and biological properties without human intervention in the device's function during the test itself (e.g., tensile strength, sterility, biocompatibility).

    7. The Type of Ground Truth Used

    The ground truth for these non-clinical tests is established by recognized international standards and specifications (e.g., ANSI/AAMI, USP, ISO 10993, ISO 11607). For instance:

    • Mechanical properties: Engineering specifications for tensile strength, dimensions.
    • Sterility: Absence of microbial growth, as defined by USP .
    • Endotoxin: Endotoxin levels below a specified threshold, as defined by ANSI/AAMI ST72.
    • Biocompatibility: Absence of cytotoxicity, sensitization, and irritation as evaluated against ISO 10993 standards and FDA guidance.
    • HSSA: A specific percentage of sperm motility after a defined period (≥70% at 24 hours).
    • Package Integrity: Meeting requirements of ISO 11607.

    8. The Sample Size for the Training Set

    Not applicable. This report details acceptance criteria and performance data for a medical device based on non-clinical testing, not a machine learning or AI algorithm that requires a training set.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable for the same reason as above (no training set for a non-AI medical device).

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1